Scholars@Duke publication: Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®)

Publication , Other

Tanaka, KA; Waly, A; Cooper, WA; Levy, JH

Published in: Anesthesiology

2003

Anesthesiology

1528-1175

2003

1513 / 1515

Lippincott, Williams & Wilkins: No Hybrid Open Access

APA

Chicago

ICMJE

MLA

NLM

Tanaka, K. A., Waly, A., Cooper, W. A., & Levy, J. H. (2003). Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®). Anesthesiology. Lippincott, Williams & Wilkins: No Hybrid Open Access.

Tanaka, K. A., A. Waly, W. A. Cooper, and J. H. Levy. “Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®).” Anesthesiology. Lippincott, Williams & Wilkins: No Hybrid Open Access, 2003.

Tanaka KA, Waly A, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®). Vol. 98, Anesthesiology. Lippincott, Williams & Wilkins: No Hybrid Open Access; 2003. p. 1513–5.

Tanaka, K. A., et al. “Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®).” Anesthesiology, vol. 98, Lippincott, Williams & Wilkins: No Hybrid Open Access, 2003, pp. 1513–15.

Tanaka KA, Waly A, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®). Anesthesiology. Lippincott, Williams & Wilkins: No Hybrid Open Access; 2003. p. 1513–1515.

Anesthesiology

1528-1175

2003

1513 / 1515

Lippincott, Williams & Wilkins: No Hybrid Open Access